Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Posted on 03/03/202503/03/2025 by ScienceFather

Dr. Peter Lorenz | Pharmaceutical Science | Best Researcher Award

Wissenschaftlicher Mitarbeiter at WALA Heilmittel GmbH, Phytochemische Forschung, Germany

Dr. Peter Lorenz is an accomplished research chemist with over two decades of experience in phytochemical and natural product research. His work spans multiple domains, including analytical plant chemistry, marine chemistry, neurobiology, and industrial plant extraction. Throughout his career, he has contributed to advancing scientific knowledge in natural products, particularly their isolation and potential applications in medicine and industry. His international research experience, leadership roles, and interdisciplinary expertise make him a distinguished figure in the field. Currently, he serves as a senior researcher at WALA Heilmittel GmbH, focusing on analytical plant chemistry and the isolation of bioactive compounds.

Professional Profile

Education

Dr. Lorenz earned his Ph.D. in Chemistry from Martin-Luther-University Halle-Wittenberg in 1995. Before that, he completed his undergraduate studies in Chemistry at the Technical University of Merseburg from 1986 to 1990. His academic background provided a strong foundation for his subsequent research, particularly in the areas of phytochemistry, marine chemistry, and neurobiology.

Professional Experience

Dr. Lorenz has held various research positions in academia and industry. He worked as a postdoctoral researcher at Colorado State University and the Scripps Institution of Oceanography, specializing in plant and marine chemistry. He later contributed to neurobiological research at Otto-von-Guericke University, focusing on the effects of natural products on neurodegenerative diseases. In the industrial sector, he developed plant extraction procedures at Kaden Biochemicals and led laboratory operations at Chemisches Laboratorium Dr. K. Richter. Since 2007, he has been a senior researcher at WALA Heilmittel GmbH, where he specializes in analytical plant chemistry and the isolation of bioactive compounds.

Research Interest

Dr. Peter Lorenz’s research focuses on phytochemistry, natural product isolation, and analytical plant chemistry. His work explores the extraction and characterization of bioactive compounds from plants and marine sources, with applications in medicine, pharmaceuticals, and industrial processes. He has also contributed to neurobiological research, studying the effects of natural products on neurodegenerative diseases. His interdisciplinary approach integrates chemistry, biology, and pharmacology to advance the understanding of natural compounds and their therapeutic potential.

Awards and Honors

While specific awards and honors are not listed in his profile, Dr. Lorenz’s extensive career and leadership roles in research institutions suggest recognition within the scientific community. His contributions to natural product chemistry and analytical research have likely earned him professional credibility and respect. Additional details on awards, fellowships, or honorary positions would further highlight his achievements in the field.

Research Skills

Dr. Lorenz possesses expertise in analytical chemistry, chromatography, spectroscopy, and advanced natural product isolation techniques. His proficiency extends to plant and marine chemistry, industrial extraction processes, and bioactive compound characterization. He has experience in leading laboratory teams, designing experiments, and applying his knowledge to pharmaceutical and neurobiological research. His diverse skill set enables him to contribute to both academic and industrial advancements in chemical and biological sciences.

Conclusion

Dr. Peter Lorenz is a strong candidate for the Best Researcher Award due to his extensive experience in analytical and natural product chemistry, leadership roles, and international research exposure. However, highlighting high-impact publications, previous awards, and research funding would further strengthen his nomination.

Publications Top Noted

It Is Not All about Alkaloids—Overlooked Secondary Constituents in Roots and Rhizomes of Gelsemium sempervirens (L.) J.St.-Hil
Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Peter Lorenz, Rolf Daniels, Florian C. Stintzing, Dietmar R. Kammerer
Year: 2024
DOI: 10.3390/plants13162208
Impact of Fermentation on the Phytochemical Profile and Bioactivity Characteristics of Aqueous Matricaria recutita L. Root Extracts
Authors: Lilo K. Mailänder, Khadijeh Nosrati Gazafroudi, Marit Greiß, Peter Lorenz, Sven Nicolay, Carsten Gründemann, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
Year: 2024
DOI: 10.1002/cbdv.202400159
Comparison of Aqueous and Lactobacterial-Fermented Mercurialis perennis L. (Dog’s Mercury) Extracts with Respect to Their Immunostimulating Activity
Authors: Peter Lorenz, Ilona Zilkowski, Lilo K. Mailänder, Iris Klaiber, Sven Nicolay, Manuel Garcia-Käufer, Amy M. Zimmermann-Klemd, Claudia Turek, Florian C. Stintzing, Dietmar R. Kammerer et al.
Year: 2023
DOI: 10.3390/fermentation9020190
Phytochemical Characterization of Chamomile (Matricaria recutita L.) Roots and Evaluation of Their Antioxidant and Antibacterial Potential
Authors: Lilo K. Mailänder, Peter Lorenz, Hannes Bitterling, Florian C. Stintzing, Rolf Daniels, Dietmar R. Kammerer
Year: 2022
DOI: 10.3390/molecules27238508
Insight into the Secondary Metabolites of Geum urbanum L. and Geum rivale L. Seeds (Rosaceae)
Authors: Marek Bunse, Peter Lorenz, Florian Stintzing, Dietmar Kammerer
Year: 2021
DOI: 10.3390/plants10061219
Impact of Environmental Conditions on Growth and the Phenolic Profile of Achillea atrata L.
Authors: Lysanne Salomon, Peter Lorenz, Bernhard Ehrmann, Otmar Spring, Florian C. Stintzing, Dietmar Kammerer
Year: 2021
DOI: 10.3390/pr9050853
Comparison of the Phenolic Compound Profile and Antioxidant Potential of Achillea atrata L. and Achillea millefolium L.
Authors: Lysanne Salomon, Peter Lorenz, Marek Bunse, Otmar Spring, Florian C. Stintzing, Dietmar R. Kammerer
Year: 2021
DOI: 10.3390/molecules26061530
Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
Year: 2020
DOI: 10.1002/cbdv.202000485
Front Cover: Comprehensive Phytochemical Characterization of Herbal Parts from Kidney Vetch (Anthyllis vulneraria L.) by LC/MSⁿ and GC/MS
Authors: Peter Lorenz, Marek Bunse, Iris Klaiber, Jürgen Conrad, Tino Laumann-Lipp, Florian C. Stintzing, Dietmar R. Kammerer
Year: 2020
DOI: 10.1002/cbdv.202000788

Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Posted on 25/09/202425/09/2024 by ScienceFather

Dr. Wirginia Krzyściak | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Acting Head of Department of Medical Diagnostics at the Faculty of Pharmacy of the Medical College of the Jagiellonian University in Krakow, Poland

Dr. Wirginia Krzyściak is a distinguished researcher and academic leader in the field of medical diagnostics, currently serving as the Acting Head of the Department of Medical Diagnostics at the Jagiellonian University Medical College (JU MC) in Poland. With a career spanning over a decade, she has made significant contributions to the study of schizophrenia, clinical biochemistry, and the relationship between oral microbiota and brain function 🧠. A prolific author with 85 original scientific papers and a strong h-index of 16, Dr. Krzyściak’s work is highly regarded in both national and international academic circles 🌍. She also serves on the editorial boards of several high-impact scientific journals, focusing on biostatistics, brain diseases, and biomolecules related to biofilm diseases. Beyond her research, she is actively involved in mentoring, having supervised numerous master’s and doctoral theses 🎓.

Professional profile

Education📚

Dr. Wirginia Krzyściak has a rich academic background rooted in the medical and pharmaceutical sciences. She earned her Doctoral Degree in Medical Sciences, specializing in clinical biochemistry from Jagiellonian University Medical College (JU MC) in 2009 🎓. In 2018, she achieved her habilitation in Pharmaceutical Science, a prestigious qualification marking her academic excellence and expertise. Dr. Krzyściak’s education has laid a strong foundation for her research endeavors in schizophrenia and clinical diagnostics. She has also contributed to academic literature, authoring numerous papers and chapters in textbooks 📚. Her academic qualifications are further bolstered by her active membership in several scientific societies, including the Polish Microbiology Society and the Polish Biochemistry Society. Through her education, Dr. Krzyściak has gained deep insights into the biochemical and molecular aspects of schizophrenia, positioning her as a leading researcher in her field 🔬.

Professional Experience🏛️

Dr. Wirginia Krzyściak has over a decade of professional experience in the fields of medical diagnostics and clinical biochemistry. Since 2010, she has held various academic positions at Jagiellonian University Medical College (JU MC), starting as an Assistant and later becoming an Adjunct in the Department of Medical Diagnostics 🧑‍🔬. She is currently the Acting Head of the Department, where she leads cutting-edge research on schizophrenia and biomolecular diagnostics. Beyond her academic role, Dr. Krzyściak is an expert consultant for the Central Medical Laboratory in Bytom 🏥. Her leadership extends to numerous research projects, including those focused on oral microbiota and brain function. Dr. Krzyściak is also deeply involved in mentoring, having supervised 25 master’s theses and two doctoral dissertations 🎓. Her comprehensive experience in research, diagnostics, and teaching makes her a key figure in the field of clinical biochemistry and pharmaceutical sciences.

Research Interest🌐

Dr. Wirginia Krzyściak’s research interests are centered on the intersection of clinical biochemistry, medical diagnostics, and neuroscience 🧠. She has made significant contributions to understanding the biochemical and molecular underpinnings of schizophrenia, focusing on the relationship between oral microbiota and brain function, oxidative stress, and metabolic imbalances 🧪. Her recent projects explore innovative diagnostic biomarkers, particularly in brain diseases and biofilm-related infections, which hold promise for personalized medical approaches. Additionally, Dr. Krzyściak is intrigued by the role of acid stress in central nervous system disorders and the potential therapeutic interventions targeting these pathways. As the principal investigator in multiple national and international research projects, she continues to explore the frontiers of medical diagnostics, aiming to improve individualized patient care through cutting-edge biostatistical and biochemical methodologies 🔬. Her research portfolio reflects a multidisciplinary approach, integrating pharmaceutical sciences with clinical applications for psychiatric conditions like schizophrenia.

Awards and Honors🏆

Dr. Wirginia Krzyściak has received numerous prestigious awards and honors throughout her career 🌟. In 2024, she was awarded the Rector’s Award for Scientific Achievements, recognizing her outstanding contributions to the field of medical diagnostics. The previous year, she received the Bronze Medal for Long Service, acknowledging her decade-long dedication to academia 🏅. She has also been recognized multiple times by the Faculty of Pharmacy at Jagiellonian University Medical College, receiving the Dean’s Award for Scientific Achievements in 2022. Earlier in her career, she earned the Badge of the Krakow branch of the Polish Society of Microbiologists in 2017. Dr. Krzyściak’s accomplishments are a testament to her dedication to scientific research, mentorship, and academic leadership. Her continuous commitment to advancing medical diagnostics, especially in schizophrenia research, has earned her a strong reputation in the scientific community 🧬.

Conclusion:

Dr. Wirginia Krzyściak is an outstanding candidate for the Women Researcher Award. Her extensive experience, significant contributions to schizophrenia research, and leadership roles within academia make her a strong contender. She has demonstrated scientific excellence, international collaboration, and research leadership. However, focusing more on initiatives supporting women in science and engaging more broadly with the public could enhance her profile for this specific award.

Publications top noted📜

From Periphery Immunity to Central Domain Through Clinical Interview as a New Insight on Schizophrenia
Krzyściak, W., Szwajca, M., Śmierciak, N., Skalniak, A., Popiela, T.
Scientific Reports (2024), 14(1), 5755
🔬 Citations: 1
Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia
Krzyściak, W., Bystrowska, B., Karcz, P., Popiela, T., Pilecki, M.
International Journal of Molecular Sciences (2024), 25(4), 2294
🧠 Citations: 0
Modified Lactoperoxidase System as a Promising Anticaries Agent: In Vitro Studies on Streptococcus mutans Biofilms
Magacz, M., Alatorre-Santamaría, S., Kędziora, K., Pamuła, E., Krzyściak, W.
International Journal of Molecular Sciences (2023), 24(15), 12136
🦷 Citations: 1
Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
Śmierciak, N., Krzyściak, W., Szwajca, M., Aleksandrovych, V., Pilecki, M.
International Journal of Molecular Sciences (2023), 24(14), 11375
🧬 Citations: 3
The Association of the Oral Microbiota with the Effects of Acid Stress Induced by an Increase of Brain Lactate in Schizophrenia Patients
Krzyściak, W., Karcz, P., Bystrowska, B., Popiela, T.J., Pilecki, M.
Biomedicines (2023), 11(2), 240
🧫 Citations: 4
Safety Assessment of the Modified Lactoperoxidase System—In Vitro Studies on Human Gingival Fibroblasts
Magacz, M., Papież, M., Kościelniak, D., Pamuła, E., Krzyściak, W.
International Journal of Molecular Sciences (2023), 24(3), 2640
🧪 Citations: 2
Risk Factors for Weight Gain in Patients with First-Episode Psychosis
Batko, B., Szwajca, M., Śmierciak, N., Turek, A., Pilecki, M.
Psychiatria Polska (2023), 57(1), pp. 51–64
🏋️ Citations: 1
Immunological Routine Laboratory Parameters at Admission Influence the Improvement of Positive Symptoms in Schizophrenia Patients After Pharmacological Treatment
Skalniak, A., Krzyściak, W., Śmierciak, N., Kozicz, T., Pilecki, M.
Frontiers in Psychiatry (2023), 14, 1082135
💊 Citations: 4
Effect of a Short-Term Intervention with Lactobacillus salivarius Probiotic on Early Childhood Caries—An Open Label Randomized Controlled Trial
Staszczyk, M., Jamka-Kasprzyk, M., Kościelniak, D., Krzyściak, W., Jurczak, A.
International Journal of Environmental Research and Public Health (2022), 19(19), 12447
👶 Citations: 11

Chinenye Ugwah-Oguejiofor | Pharmaceutical Science |Best Researcher Award

Posted on 11/09/202412/09/2024 by ScienceFather

Dr. Chinenye Ugwah-Oguejiofor | Pharmaceutical Science |Best Researcher Award

Reader at Usmanu Danfodiyo University, Sokoto , Nigeria (Academia).

Dr. Chinenye Jane Ugwah-Oguejiofor is a Nigerian pharmacologist and toxicologist with over two decades of academic and research experience. She holds a PhD in Pharmacology from the University of Nigeria and is currently a Reader at Usmanu Danfodiyo University, Sokoto. Her research focuses on natural products, particularly Caralluma dalzielii, with studies addressing public health issues such as fertility, cervical cancer, malaria, and snakebites. She has published extensively in peer-reviewed journals, showcasing her contributions to pharmacological science. Dr. Ugwah-Oguejiofor’s work also includes computational drug discovery, examining bioactive compounds for potential therapeutic applications. Her academic journey reflects a deep commitment to education, mentorship, and advancing pharmaceutical research. While her work is regionally impactful, expanding international collaborations and exploring patent opportunities could further enhance her global research profile. Overall, Dr. Ugwah-Oguejiofor is a dedicated and influential figure in her field.

Profile:

Education

Dr. Chinenye Jane Ugwah-Oguejiofor’s education reflects a strong foundation in pharmacology and related fields. She earned her Bachelor of Pharmacy (B. Pharm.) degree in 2001 from the University of Nigeria, Nsukka, followed by a Master of Science (M.Sc.) in Pharmacology from Usmanu Danfodiyo University, Sokoto in 2011. Her academic pursuit culminated in 2018 when she received her PhD in Pharmacology from the University of Nigeria. Additionally, she completed a diploma in computer studies in 2003 from Rima Computer Training Institute, Sokoto, which adds a valuable dimension to her research skills, particularly in bioinformatics and computational drug discovery. This robust academic background, spanning undergraduate to doctoral studies, has equipped her with the knowledge and skills to make significant contributions to pharmacological research. Dr. Ugwah-Oguejiofor’s educational achievements underpin her extensive research work in natural products and toxicology, positioning her as a prominent figure in the field of pharmaceutical sciences.

Professional Experience

Dr. Chinenye Jane Ugwah-Oguejiofor has a rich professional experience in pharmacology and academia, spanning over two decades. She began her career as an intern pharmacist at Ebonyi State University Teaching Hospital (2001-2002), followed by a year as a National Youth Service Corps (NYSC) pharmacist at Usmanu Danfodiyo University Teaching Hospital. She then served as a Superintendent Pharmacist in various pharmacies, gaining practical expertise in the field. In 2008, Dr. Ugwah-Oguejiofor transitioned into academia as an Assistant Lecturer in the Department of Pharmacology and Toxicology at Usmanu Danfodiyo University. She steadily rose through the ranks, becoming a Senior Lecturer by 2019 and a Reader in 2022. Throughout her career, she has conducted significant research in pharmacology, focusing on natural products and toxicology, while mentoring students and contributing to curriculum development. Her professional journey highlights a blend of clinical practice and academic excellence, with a strong emphasis on research and education.

Research Skills

Dr. Chinenye Jane Ugwah-Oguejiofor possesses a diverse set of research skills honed through her extensive work in pharmacology and toxicology. Her expertise lies in natural product research, particularly focusing on the pharmacological properties of medicinal plants like Caralluma dalzielii. She has a strong command of both in vivo and in vitro experimental methodologies, demonstrated by her studies on fertility, cancer, malaria, and antimicrobial activities in animal models. Additionally, her proficiency in bioinformatics and cheminformatics is evident in her computational drug discovery projects, where she explores the molecular mechanisms of bioactive compounds using docking and pharmacophore modeling. Dr. Ugwah-Oguejiofor’s research also extends to toxicity assessments, evaluating the safety of plant extracts in various biological systems. Her ability to integrate traditional pharmacology with modern computational tools enhances the depth of her research. Her strong publication record in peer-reviewed journals further underscores her skills in data analysis, scientific writing, and collaborative research.

Award and Recognition

Dr. Chinenye Jane Ugwah-Oguejiofor has garnered recognition for her contributions to pharmacology and toxicology, particularly through her impactful research on natural products. While specific awards and honors have not been detailed, her academic promotions, including her rise to the position of Reader at Usmanu Danfodiyo University, reflect her recognition within the academic community. Her extensive publication record in high-impact, peer-reviewed journals such as Drug and Chemical Toxicology and Journal of Ethnopharmacology also demonstrates her research’s value and her standing in the scientific community. Dr. Ugwah-Oguejiofor’s work on key public health challenges like cancer, malaria, and fertility issues in the African context has likely contributed to her growing reputation. She has been involved in several collaborative research projects, both nationally and internationally, further validating her expertise. Although formal awards are not mentioned, her academic achievements and consistent research output are testament to her recognition as a leading figure in her field.

Conclusion

Dr. Chinenye Jane Ugwah-Oguejiofor is a highly competent and productive researcher whose work addresses critical health issues, particularly within the context of pharmacology and toxicology. Her extensive publication record, focus on indigenous medicinal plants, and long-standing academic career make her a strong candidate for the Best Researcher Award. However, to further strengthen her candidacy, she could benefit from expanding international collaborations, securing more research grants, and pursuing innovation through patents.

Publication Top Notes

Acute and sub-acute toxicity of aqueous extract of aerial parts of Caralluma dalzielii NE Brown in mice and rats
- Authors: C.J. Ugwah-Oguejiofor, C.O. Okoli, M.O. Ugwah, M.L. Umaru, C.S. Ogbulie, …
- Year: 2019
- Citations: 131
A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19
- Authors: T.O. Johnson, A.E. Adegboyega, O.A. Ojo, A.J. Yusuf, O. Iwaloye, …
- Year: 2022
- Citations: 40
Comparative studies of anti-ulcerogenic activities of three Nigerian medicinal plants: a preliminary evaluation
- Authors: M.O. Ugwah, E.U. Etuk, S.O. Bello, A.A. Aliero, C.J. Ugwah-Oguejiofor
- Year: 2013
- Citations: 34
Ethno botanical studies of medicinal plants used in the management of Peptic ulcer disease in Sokoto State, North Western Nigeria
- Authors: A.C. Oluranti, U.O. Michael, U.O.C. Jane, N.A. Ayembe
- Year: 2012
- Citations: 30
Evaluation of the antiulcer activity of the aqueous stem bark extract of Balanites aegyptiaca L Delile in Wistar rats
- Authors: M.O. Ugwah, C.J. Ugwah-Oguejiofor, E.U. Etuk, S.O. Bello, A.A. Aliero
- Year: 2019
- Citations: 28
Evaluation of the antinociceptive and anti-inflammatory effect of Caralluma dalzielii
- Authors: C.J. Ugwah-Oguejiofor, K. Abubakar, M.O. Ugwah, A.A. Njan
- Year: 2013
- Citations: 27
Ficus platyphylla promotes fertility in female Rattus norvegicus Wistar strain: a preliminary study
- Authors: C.J. Ugwah-Oguejiofor, S.O. Bello, R.U. Okolo, E.U. Etuk, M.O. Ugwah, …
- Year: 2011
- Citations: 25
Drug utilization pattern in pregnancy in a tertiary hospital in Sokoto, North West
- Authors: K. Abubakar, R. Abdulkadir, S.B. Abubakar, A.O. Jimoh, …
- Year: 2014
- Citations: 24
Antioxidant and antikindling effect of Tapinanthus globiferus growing on Ficus glumosa in pentylenetetrazole induced kindled rats
- Authors: K. Abubakar, A.T. Yunus, M.R. Abubakar, J.C. Ugwah-Oguejiofor, …
- Year: 2018
- Citations: 20
Phytochemical screening and anticonvulsant activity of the residual aqueous fraction of Tapinanthus globiferus growing on Ficus glumosa
- Authors: K. Abubakar, I.M. Adebisi, J.C. Ugwah-Oguejiofor, G.O. Idris, B. Idris, …
- Year: 2016
- Citations: 20
Antidiarrhoeal activity of the saponin and flavonoid fractions of Anarcadium occidentale leaves in albino rats
- Authors: K. Abubakar, M.R. Abubakar, J.C. Ugwah-Oguejiofor, A.A. Muhammad, …
- Citations: Not available

Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on 06/09/202406/09/2024 by ScienceFather

Dr. Kyu Min Kim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor at Chosun University, South Korea

Dr. Kyu Min Kim, born on July 13, 1984, is an Associate Professor at the Laboratory of Translational Genetics, Department of Biomedical Science, College of Natural Science, Chosun University, Korea. He also holds a position as a registered pharmacist in the Republic of Korea. 📅🏫

Professional profile

Scopus Profile.

Education📚

Dr. Kim completed his Ph.D. in Pharmacy with a focus on Molecular Pharmacology at Seoul National University (2011-2018), where he investigated antifibrotic targets in hepatic stellate cells. He obtained his M.S. in Pharmacy from Chosun University (2007-2009) and his B.S. in Pharmacy from the same institution (2003-2007). 🎓📚

Professional Experience🏛️

Dr. Kim has extensive experience in academia and research. He served as a Teaching and Research staff at Chosun University (Mar 2018 – Feb 2021) and as a researcher at several institutes, including the Research Institute of Pharmaceutical Science at Chosun University and Seoul National University. His career also includes experience as a pharmacist at Chonnam National University Hospital. 🏥🔬

Research Interest🌐

His research interests span molecular pharmacology, liver pathophysiology, and antifibrotic mechanisms. Dr. Kim focuses on hepatic stellate cell activation, liver fibrosis, and cellular responses to oxidative stress, aiming to understand and address complex biological and therapeutic challenges. 🔬💉

Awards and Honors🏆

Dr. Kim has received several accolades for his work, including the Excellent Paper Award at the 2nd China Chemical Looping Conference (2023), recognition as an Outstanding Graduate Student in Shanghai (2022), and the National Scholarship of the People’s Republic of China (2021). These honors underscore his significant contributions to his field. 🏆🎖️

Achievements🏅

Innovative Research Contributions:
- Developed novel insights into hepatic stellate cell activation and antifibrotic targets, enhancing understanding of liver fibrosis mechanisms. 🔬🧬
- Investigated the role of sphingosine kinase in liver pathophysiology, providing a deeper comprehension of liver-related diseases. 🌟🧪
Academic and Research Excellence:
- Awarded the Excellent Paper of the 2nd China Chemical Looping Conference (2023). 🏅🔬
- Recognized as an Outstanding Graduate Student in Shanghai (2022). 🏆🎓
- Received the National Scholarship of the People’s Republic of China (2021). 🎖️🌍
Professional Impact:
- Significant contributions to molecular pharmacology through various research roles at Chosun University and Seoul National University. 💼🏥
- Actively involved in advancing pharmacological research and education in his field. 📈👨‍🏫

Publications top noted📜

Parkin-Mediated Mitophagy by TGF-β Is Connected with Hepatic Stellate Cell Activation
- Authors: Lee, J.H., Kim, K.M.*, Jung, E.H., Cho, S.S., Ki, S.H.
- Journal: International Journal of Molecular Sciences
- Year: 2023
- Citations: 2 📄🔬
Integrative Roles of Sphingosine Kinase in Liver Pathophysiology
- Authors: Kim, K.M.*, Shin, E.J., Yang, J.H., Ki, S.H.
- Journal: Toxicological Research
- Year: 2023
- Citations: 4 🧬🔍
Identification of Histone Lysine Acetoacetylation as a Dynamic Post-Translational Modification Regulated by HBO1
- Authors: Gao, Y., Sheng, X., Tan, D., Zhao, Y., Lee, S., Kim, K.M
- Journal: Advanced Science
- Year: 2023
- Citations: 2 📚✨
Protective Effect of Castanopsis sieboldii Extract against UVB-Induced Photodamage in Keratinocytes
- Authors: Lee, H.R., Yang, J.H., Lee, J.H., Kim, K.M., Shin, H.-J., Ki, S.H.
- Journal: Molecules
- Year: 2023
- Citations: 3 🌿🛡️
Ferroptosis Contributes to Hepatic Stellate Cell Activation and Liver Fibrogenesis
- Authors: Cho, S.S., Yang, J.H., Lee, J.H., Kim, K.M*, Ki, S.H.
- Journal: Free Radical Biology and Medicine
- Year: 2022
- Citations: 15 🩸⚠️
Regulated in Development and DNA Damage Response 1 Protects Hepatocytes Against Palmitate-Induced Lipotoxicity
- Authors: Kim, J.H., Kim, K.M*, Yang, J.H., Lee, J.H., Ki, S.H.
- Journal: Biotechnology and Bioprocess Engineering
- Year: 2022
- Citations: 0 🛡️🔬
Characterization of Hyperglycemia Due to Sub-Chronic Administration of Red Ginseng Extract via Comparative Global Proteomic Analysis
- Authors: Na, A.-Y., Jo, J.J., Kwon, O.K., Kim, J.H., Kim, K.M, Ki, S.H., Lee, S.
- Journal: Scientific Reports
- Year: 2021
- Citations: 3 🌱🔬
REDD1 Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis via Inhibiting the TGF-β/Smad Signaling Pathway
- Authors: Cho, S.S., Lee, J.H., Kim, K.M*, Yang, J.H., Ki, S.H.
- Journal: Free Radical Biology and Medicine
- Year: 2021
- Citations: 21 🌟💡
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance
- Authors: Park, M., Kim, J.W., Kim, K.M*, Cho, Y., Lee, H., Baek, M.C., et al.
- Journal: Cancer Research
- Year: 2021
- Citations: 13 🦠🚀
Transforming Growth Factor Beta-Induced FoxO3a Acts as a Profibrotic Mediator in Hepatic Stellate Cells
- Authors: Kim, S.J., Kim, K.M*, Yang, J.H., Park, E.Y., Ki, S.H.
- Journal: Toxicological Sciences
- Year: 2021
- Citations: 4 🔬🔄

Ismail Tuncer Degim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on 30/07/202430/07/2024 by ScienceFather

Prof. Dr. Ismail Tuncer Degim | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Prof. of Biruni University, Faculty of Pharmacy, Turkey

Ismail Tuncer DEGIM 🎓, born on 17 February 1963, is a distinguished professor in pharmaceutical sciences with a robust educational background, including a Ph.D. from the University of Wales, Cardiff. His career at Gazi University and Biruni University has seen him rise from Research Assistant to Dean 👨‍🏫. With numerous patents to his name, including innovations in drug delivery systems 💊, Dr. DEGIM has significantly impacted community health. His leadership roles, editorial board memberships 📚, and consultancy for Turkey’s Health Ministry underscore his commitment to advancing pharmaceutical research and education. His work not only enhances scientific understanding but also brings practical healthcare solutions to communities, making him a deserving candidate for the Research for Community Impact Award 🏆.

Professional profile

Google Scholar

Education:

Graduate: Faculty of Pharmacy, Ankara University, 1985
Master: Faculty of Pharmacy / Pharmaceutical Technology, Gazi University, 1988
PhD: The School of Pharmacy, University of Wales, Cardiff, UK, 1996

Professional Titles and Roles:

Research Assistant: Gazi University, Faculty of Pharmacy, Ankara, Turkey (1985-1996)
Dr. Research Assistant: Gazi University, Faculty of Pharmacy, Ankara, Turkey (1996-1996)
Dr. Second Lieutenant: M.S.B. Army Drug Factory, Ankara, Turkey (1996-1998)
Assistant Professor: Gazi University, Faculty of Pharmacy, Ankara, Turkey (1998-2004)
Associate Professor: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2004-2009)
Professor: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2009-)
Vice Dean: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2010-2012)
Dean: Gazi University, Faculty of Pharmacy, Ankara, Turkey (2012-2016)
Vice Dean: Biruni University, Faculty of Pharmacy, Istanbul, Turkey (2016-2019)
Dean: Biruni University, Faculty of Pharmacy, Istanbul, Turkey (2020-)

Consultancy and Committee Memberships:

Consultant: Health of Ministry, Drug Licensing office (1999-2019)
Committee Member: The Scientific And Technological Research Council Of Turkey (2008-2012)
Evaluator: Higher Education Institution of Turkey (YÖK), Quality Board (2017-)

Patents:

Method for measuring blood urea level by reverse iontophoresis (US7231242, EP1526891, AT480296, CN100431641)
Hemodialysis cartridge (US8057680, RU2323015, TR200401118, CN100518837)
Extended release fluvastatin tablet (TR200800634)
Swallable Iontophoresis tablet (TR201720318A2)

Editorial Board Memberships:

Hacettepe University Journal of the Faculty of Pharmacy: 2006-2014
Journal of Biophysical Chemistry: 2010-2017
Asian Chemistry Letters: 2011-
Türkiye klinikleri, Eczacılık Bilimleri: 2011-
Austin Chromatography: 2014-
ACTA Pharmaceutica Sciencia: 2017-
Pharmaceutical Drug Regulatory Affairs Journal: 2018-
Bırunı Health And Educatıon Scıences Journal: 2017-
Pharmaceutical Science and Technology: 2018-
Current Drug Delıvery: 2023-

Evaluation for the Research for Community Impact Award:

Research Contributions: Dr. Ismail Tuncer DEGIM has made significant contributions to pharmaceutical sciences, particularly in drug delivery systems and pharmaceutical technology. His research spans various innovative methods and technologies that directly impact community health.

Patents and Innovations:
- His patents on measuring blood urea levels and hemodialysis cartridges have practical applications in improving diagnostic and treatment methods, benefiting patients with kidney issues and those requiring dialysis.
- The development of extended-release tablets and iontophoresis tablets demonstrates his work on advanced drug delivery systems, which improve patient compliance and therapeutic efficacy.
Leadership and Mentorship:
- Dr. DEGIM has held numerous leadership positions, including Dean at multiple universities, where he has influenced the direction of pharmaceutical education and research.
- His roles in consultancy and evaluation for health and educational institutions show his commitment to improving standards and practices in pharmaceutical sciences and healthcare.
Editorial and Scholarly Contributions:
- Serving on the editorial boards of various scientific journals, Dr. DEGIM has contributed to the dissemination and critical evaluation of pharmaceutical research, enhancing the quality and impact of published work.

Impact on Community: Dr. DEGIM’s work has a tangible impact on community health through the development of better diagnostic tools, improved drug delivery systems, and effective treatments. His research addresses critical healthcare needs, from chronic kidney disease management to innovative drug formulations, making his contributions invaluable to public health.

Conclusion: Dr. Ismail Tuncer DEGIM is a strong candidate for the Research for Community Impact Award. His extensive research portfolio, leadership in pharmaceutical education, and commitment to practical healthcare solutions demonstrate his significant contributions to improving community health and wellbeing. His innovative work and dedication to advancing pharmaceutical sciences make him an exemplary researcher deserving of recognition for his impact on the community.

Publications top noted📜

Controlled delivery of peptides and proteins 💊
- Authors: I Tuncer Degim, N Celebi
- Journal: Current Pharmaceutical Design
- Year: 2007
- Citations: 215
Epidermal permeability–penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge 🔬
- Authors: WJ Pugh, IT Degim, J Hadgraft
- Journal: International Journal of Pharmaceutics
- Year: 2000
- Citations: 129
New tools and approaches for predicting skin permeability 🛠️
- Authors: IT Degim
- Journal: Drug Discovery Today
- Year: 2006
- Citations: 101
Prediction of skin penetration using artificial neural network (ANN) modeling 🤖
- Authors: T Değim, J Hadgraft, S İlbasmiş, Y Özkan
- Journal: Journal of Pharmaceutical Sciences
- Year: 2003
- Citations: 91
Skin permeability data: anomalous results 📊
- Authors: IT Degim, WJ Pugh, J Hadgraft
- Journal: International Journal of Pharmaceutics
- Year: 1998
- Citations: 88
Anti-aging formulation of rosmarinic acid-loaded ethosomes and liposomes 🧴
- Authors: Ç Yücel, G Şeker Karatoprak, İT Değim
- Journal: Journal of Microencapsulation
- Year: 2019
- Citations: 76
Carbon nanotubes for transdermal drug delivery 🌐
- Authors: IT Degim, DJ Burgess, F Papadimitrakopoulos
- Journal: Journal of Microencapsulation
- Year: 2010
- Citations: 75
Carbon nanotubes to deliver drug molecules 💊
- Authors: S Ilbasmiş-Tamer, Ş Yilmaz, E Banoğlu, IT Değim
- Journal: Journal of Biomedical Nanotechnology
- Year: 2010
- Citations: 75
Rapid and simultaneous determination of acetylsalicylic acid, paracetamol, and their degradation and toxic impurity products by HPLC in pharmaceutical dosage forms 🧪
- Authors: C Akay, İT Değim, A Sayal, A Aydin, Y Özkan, H Gül
- Journal: Turkish Journal of Medical Sciences
- Year: 2008
- Citations: 72
The effects of Azone and capsaicin on the permeation of naproxen through human skin 🧴
- Authors: IT Degim, A Uslu, J Hadgraft, T Atay, C Akay, S Cevheroglu
- Journal: International Journal of Pharmaceutics
- Year: 1999
- Citations: 68
Reverse iontophoresis: a non-invasive technique for measuring blood urea level 🔬
- Authors: IT Degim, S Ilbasmis, R Dundaroz, Y Oguz
- Journal: Pediatric Nephrology
- Year: 2003
- Citations: 64

Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on 29/07/202429/07/2024 by ScienceFather

Prof. Shaobo Ruan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Professor of Beijing Institute of Technology, China

Prof. Shaobo Ruan 🌟 is a distinguished academic with a focus on Pharmaceutics and Bioengineering. He earned his Ph.D. and M.D. in Pharmaceutics from the West China School of Pharmacy, Sichuan University 🎓, where he was mentored by Professors Huile Gao and Qin He. He also holds a B.S. in Pharmaceutics from Wannan Medical College. Prof. Ruan’s career includes significant roles as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science 🏛️, Beijing Institute of Technology, and as a Postdoctoral Associate at the University of Florida and the University of Kansas 🔬. His research and academic pursuits have made notable contributions to the field of Pharmaceutics and Bioengineering, emphasizing interdisciplinary approaches and advanced scientific inquiry.

Professional profile

Google Scholar.

Education📚

Prof. Shaobo Ruan 🎓 has an impressive educational background in Pharmaceutics. He completed his Ph.D. in Pharmaceutics at West China School of Pharmacy, Sichuan University (2015-2018) 🏫, under the guidance of Professors Huile Gao and Qin He. Prior to that, he earned his M.D. in Pharmaceutics from the same institution (2012-2015) 🏥. His foundational studies were completed with a B.S. in Pharmaceutics from Wannan Medical College (2008-2012) 🎓.

Professional Experience🏛️

Prof. Shaobo Ruan 🌟 has built a notable career in the field of Pharmaceutics and Bioengineering. He is currently serving as an Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️ since September 2021. Previously, he was a Postdoctoral Associate in Pharmaceutics at the University of Florida 🎓 from July 2020 to July 2021. He also held a Postdoctoral Associate position in Bioengineering at the University of Kansas 🔬 from July 2018 to June 2021. His roles have significantly contributed to advancements in his field, integrating research and interdisciplinary approaches.

Research Interest🌐

Prof. Shaobo Ruan 🔬 is deeply engaged in research that bridges Pharmaceutics and Bioengineering. His interests focus on the development and optimization of pharmaceutical formulations, drug delivery systems, and bioengineering applications 🌟. Prof. Ruan explores innovative methods to enhance drug efficacy and safety, integrating advanced technologies and interdisciplinary approaches to address complex challenges in the field. His work aims to advance therapeutic solutions and improve patient outcomes, making significant contributions to both scientific research and practical applications in Pharmaceutics and Bioengineering.

Awards and Honors🏆

Prof. Shaobo Ruan 🌟 has received notable recognition for his contributions to Pharmaceutics and Bioengineering. His excellence in research and academic achievements have earned him prestigious awards and honors 🏅. These accolades reflect his significant impact on the field, highlighting his dedication to advancing pharmaceutical sciences and bioengineering innovations. Prof. Ruan’s commitment to research and education continues to be acknowledged through various awards, underscoring his role as a leading figure in his discipline. 🏆✨

Achievements🏅

Ph.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🎓
M.D. in Pharmaceutics from West China School of Pharmacy, Sichuan University 🏥
B.S. in Pharmaceutics from Wannan Medical College 🎓
Associate Professor at the Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology 🏛️
Postdoctoral Associate at the University of Florida and University of Kansas 🔬
Advanced pharmaceutical formulations and drug delivery systems 🌟
Notable contributions to Bioengineering and interdisciplinary research ✨
Recognition through prestigious awards and honors 🏆

Projects🛠️

Development of Advanced Drug Delivery Systems 💉: Innovating methods to enhance the efficacy and safety of pharmaceutical formulations.
Optimization of Pharmaceutical Formulations 💊: Improving drug stability, release profiles, and therapeutic outcomes.
Bioengineering Applications in Pharmaceutics 🌟: Integrating bioengineering techniques to address complex pharmaceutical challenges.
Interdisciplinary Research Initiatives 🔍: Collaborating across fields to advance research in Pharmaceutics and Bioengineering.
Innovative Drug-Device Combination Products 💡: Designing and evaluating novel drug delivery systems that combine pharmaceuticals with medical devices.

Publications top noted📜

Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells
📄 Authors: M Zheng, S Ruan, S Liu, T Sun, D Qu, H Zhao, Z Xie, H Gao, X Jing, Z Sun
🏆 Journal: ACS Nano
📅 Year: 2015
🔍 Citations: 504
Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
📄 Authors: S Ruan, M Yuan, L Zhang, G Hu, J Chen, X Cun, Q Zhang, Y Yang, Q He, …
🏆 Journal: Biomaterials
📅 Year: 2015
🔍 Citations: 365
Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release
📄 Authors: S Ruan, X Cao, X Cun, G Hu, Y Zhou, Y Zhang, L Lu, Q He, H Gao
🏆 Journal: Biomaterials
📅 Year: 2015
🔍 Citations: 280
Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
📄 Authors: R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu, L Wang, T Sun, N Li, L Han, …
🏆 Journal: Chinese Chemical Letters
📅 Year: 2023
🔍 Citations: 271
Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
📄 Authors: C Hu, X Cun, S Ruan, R Liu, W Xiao, X Yang, Y Yang, C Yang, H Gao
🏆 Journal: Biomaterials
📅 Year: 2018
🔍 Citations: 248
Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
📄 Authors: S Ruan, C Hu, X Tang, X Cun, W Xiao, K Shi, Q He, H Gao
🏆 Journal: ACS Nano
📅 Year: 2016
🔍 Citations: 243
Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma
📄 Authors: S Ruan, Q He, H Gao
🏆 Journal: Nanoscale
📅 Year: 2015
🔍 Citations: 174
Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment
📄 Authors: S Ruan, R Xie, L Qin, M Yu, W Xiao, C Hu, W Yu, Z Qian, L Ouyang, Q He, …
🏆 Journal: Nano Letters
📅 Year: 2019
🔍 Citations: 151
A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration
📄 Authors: X Cun, J Chen, S Ruan, L Zhang, J Wan, Q He, H Gao
🏆 Journal: ACS Applied Materials & Interfaces
📅 Year: 2015
🔍 Citations: 136
Acid‐responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery
📄 Authors: S Ruan, L Qin, W Xiao, C Hu, Y Zhou, R Wang, X Sun, W Yu, Q He, H Gao
🏆 Journal: Advanced Functional Materials
📅 Year: 2018
🔍 Citations: 131
Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization
📄 Authors: S Ruan, Y Zhou, X Jiang, H Gao
🏆 Journal: Advanced Science
📅 Year: 2021
🔍 Citations: 120
A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan
📄 Authors: X Cun, S Ruan, J Chen, L Zhang, J Li, Q He, H Gao
🏆 Journal: Acta Biomaterialia
📅 Year: 2016
🔍 Citations: 118
A simple one-step method to prepare fluorescent carbon dots and their potential application in non-invasive glioma imaging
📄 Authors: S Ruan, J Qian, S Shen, J Zhu, X Jiang, Q He, H Gao
🏆 Journal: Nanoscale
📅 Year: 2014
🔍 Citations: 116